Minocycline protects the immature white matter against hyperoxia
Thomas Schmitz1, Grietje Krabbe2, Georg Weikert1
1Department for Neonatology, Charité University Medical Center, Berlin, Germany.
Insights
Minocycline protects developing white matter in neonatal rats from oxygen toxicity by inhibiting microglia and directly supporting oligodendroglia. This treatment improves long-term white matter integrity after hyperoxia exposure.
Area of Science:
- Neuroscience
- Neonatal Research
- Pharmacology
Background:
- Periventricular white matter damage in preterm infants is linked to poor neurological outcomes.
- Hyperoxia, common in preterm infants, exacerbates white matter injury by causing inflammation and hypoxia-ischemia.
- Minocycline shows neuroprotective effects in animal models by inhibiting microglial activation.
Purpose of the Study:
- To investigate the protective effects of minocycline on white matter damage induced by hyperoxia in neonatal rats.
- To determine if minocycline prevents microglial activation and protects oligodendroglial precursor cells (OPCs) during hyperoxia.
- To assess the long-term impact of minocycline treatment on white matter integrity after neonatal hyperoxia.
Main Methods:
- Neonatal rats were exposed to hyperoxia (80% O2) from postnatal day 6 to 7 to model preterm birth conditions.
- Minocycline was administered during hyperoxia exposure, and its effects on microglial activation, OPC development, and cell death were analyzed.
- Magnetic Resonance Imaging (MRI) with Diffusion Tensor Imaging (DTI) was used to evaluate long-term white matter integrity at postnatal days 30 and 60.
Main Results:
- Minocycline treatment reduced apoptotic cell death and enhanced the proliferation and maturation of OPCs.
- Hyperoxia-induced changes in microglial morphology and IL-1β release were inhibited by minocycline.
- Minocycline treatment attenuated long-term white matter diffusivity impairments observed in MRI/DTI scans.
Conclusions:
- Minocycline protects white matter development against oxygen toxicity by directly safeguarding oligodendroglia and inhibiting microglial activation.
- The study demonstrates that minocycline provides significant long-term benefits for white matter integrity following neonatal hyperoxia.
- Minocycline represents a potential therapeutic agent for preventing or mitigating white matter injury in vulnerable preterm infants.
Abstract:
Poor neurological outcome in preterm infants is associated with periventricular white matter damage and hypomyelination, often caused by perinatal inflammation, hypoxia-ischemia, and hyperoxia. Minocycline has been demonstrated in animal models to protect the immature brain against inflammation and hypoxia-ischemia by microglial inhibition. Here we studied the effect of minocycline on white matter damage caused by hyperoxia. To mimic the 3- to 4-fold increase of oxygen tension caused by preterm birth, we have used the hyperoxia model in neonatal rats providing 24h exposure to 4-fold increased oxygen concentration (80% instead of 21% O2) from P6 to P7. We analyzed whether minocycline prevents activation of microglia and damage of oligodendroglial precursor cell development, and whether acute treatment of hyperoxia-exposed rats with minocycline improves long term white matter integrity. Minocycline administration during exposure to hyperoxia resulted in decreased apoptotic cell death and in improved proliferation and maturation of oligodendroglial precursor cells (OPC). Minocycline blocked changes in microglial morphology and IL-1β release induced by hyperoxia. In primary microglial cell cultures, minocycline inhibited cytokine release while in mono-cultures of OPCs, it improved survival and proliferation. Long term impairment of white matter diffusivity in MRI/DTI in P30 and P60 animals after neonatal hyperoxia was attenuated by minocycline. Minocycline protects white matter development against oxygen toxicity through direct protection of oligodendroglia and by microglial inhibition. This study moreover demonstrates long term benefits of minocycline on white matter integrity.
